LINC-PINT is referred to directly bind EZH2 and the knockdown of EZH2 partially counteracts the promoting effects of LINC-PINT overexpression on the malignant behaviors of ccRCC cells [33]. Here, LINC-PINT is linked to nonpapillary renal cell carcinoma.